Bridgewater Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
CIP
BCM
BG
Bridgewater Advisors's TNDM Position: Q2 2022 in Review
Bridgewater Advisors sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,000 shares — an estimated $233K sold.
Bridgewater Advisors first reported a position in TNDM in Q3 2021 and held it in 3 quarters. The position peaked at $301K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.
- Bridgewater Advisors reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
- Bridgewater Advisors sold 2,000 Tandem Diabetes Care shares in Q2 2022, an estimated $233K.
- Bridgewater Advisors first reported a position in Tandem Diabetes Care in Q3 2021 and held it in 3 quarters.
- Bridgewater Advisors's Tandem Diabetes Care position peaked at $301K in Q4 2021.
- 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.
Based on Bridgewater Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.